Sponsors (5)
The bill expands research, training, standardized guidance, and reimbursement to improve diagnosis and access for restorative reproductive medicine and infertility care, but it risks narrowing reproductive‑health options, increasing administrative and fiscal costs, and creating uneven access to assisted reproductive technologies depending on coverage and conscience protections.
People with infertility and chronic reproductive conditions (women and men) gain broader, better‑coordinated diagnosis and treatment options because the bill promotes restorative reproductive medicine, bundles reimbursable services, and standardizes care pathways across HHS programs.
Providers, clinicians, and trainees receive expanded education, training materials, and standardized clinical guidance that can improve provider knowledge and consistency of reproductive‑health care.
Medicare/Medicaid and other payers will get new coding, assigned RVUs, and clearer reimbursement pathways for restorative reproductive services, improving provider payment and incentivizing delivery of complex reproductive care.
Women and others may face narrower reproductive‑health options because the bill emphasizes 'restorative' and fertility‑awareness approaches, which could be used to deprioritize contraception, abortion‑related care, or some assisted reproductive technologies in funded programs and guidance.
Patients seeking assisted reproductive technology (ART) could face reduced access or delays because the bill allows providers and federally funded entities to refuse to provide, refer for, or arrange ART without federal penalty.
Expanding reimbursement codes, research, reporting, Title X eligibility, and program requirements will raise short‑term and ongoing administrative burdens and costs for HHS, CMS, states, clinics, and grant applicants, which could divert staff time from care delivery.
Based on analysis of 14 sections of legislative text.
Expands HHS research, training, coding, reimbursement, and federal program eligibility to promote restorative reproductive medicine, fertility awareness education, and NaProTechnology, and protects providers who decline ART participation.
Official title: Expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions, and for other purposes.
Introduced May 22, 2025 by Cindy Hyde-Smith · Last progress May 22, 2025
Directs HHS to expand research, training, coding, reimbursement, data collection, and federal program eligibility to support "restorative reproductive medicine," fertility awareness–based methods, and NaProTechnology. It conditions Title X grants on training requirements for the Reproductive Health National Training Center, requires updates to medical coding and reimbursement for infertility and related procedures, mandates research and reporting, and creates protections for providers who decline to participate in assisted reproductive technology on moral or religious grounds. The bill also tasks CDC and HHS offices with adding survey questions and education programs, opens Title X and the Teen Pregnancy Prevention program to entities primarily engaged in restorative reproductive medicine, and requires multiple reports and timelines for implementation and rulemaking over 1–3 year periods.